In December 2019, a novel coronavirus was isolated from the respiratory epithelium of
patients with unexplained pneumonia in Wuhan, China. This pathogen, named severe acute …

Severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2) causes a wide spectrum of
clinical manifestations, with progression to multiorgan failure in the most severe cases …

In December 2019, an outbreak of viral pneumonia caused by a novel coronavirus (since
named SARS-CoV-2) was identified in Wuhan, China. Within few months, this disease–now …

Severe acute respiratory disease coronavirus 2 (SARS-CoV-2, formerly 2019-nCoV) is a
novel coronavirus that has rapidly disseminated worldwide, causing the coronavirus disease …

Background Patients with COVID-19-related acute respiratory distress syndrome (ARDS)
have been postulated to present with distinct respiratory subphenotypes. However, most …

The primary objective of this multicenter, observational, retrospective study was to assess
the incidence rate of ventilator-associated pneumonia (VAP) in coronavirus disease 2019 …

There is growing evidence regarding chest X-ray and computed tomography (CT) findings
for coronavirus disease 2019 (COVID-19). At present, the role of lung ultrasonography (LUS) …

Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection of
the respiratory system can progress to a multisystemic disease with aberrant inflammatory …

The latest guidelines for the hospital care of patients affected by coronavirus disease 2019
(COVID-19)-related acute respiratory failure have moved towards the widely accepted use of …

In late 2019, an outbreak of a novel human coronavirus causing respiratory disease was
identified in Wuhan, China. The virus spread rapidly worldwide, reaching pandemic status …